Anglogold Ashanti Analyst Price Targets

Wall Street analyst price targets and consensus rating for Anglogold Ashanti (AU).

Price Target Range — 11 Quarters

Analyst Consensus — 7 Analysts

6Buy

1Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$110Upside to Avg. PT+26.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 22, 2026	Freedom Broker	Vitaly Kononov	PT Raise	Buy	$107→$112
Oct 15, 2026	Goldman Sachs	Matt Greene	Initiate	Buy	$104
Sep 16, 2026	RBC Capital	Josh Wolfson	PT Raise	Outperform	$111→$119
Sep 15, 2026	JP Morgan	Patrick Jones	PT Raise	Overweight	$134→$140
Sep 10, 2026	BMO Capital	Raj Ray	Downgrade	Outperform→Market Perform	$115
Jul 16, 2026	JP Morgan	Patrick Jones	PT Cut	Overweight	$155→$134
Jul 15, 2026	Citigroup	Ephrem Ravi	PT Cut	Buy	$130→$125
Jul 14, 2026	Scotiabank	Tanya Jakusconek	PT Cut	Sector Outperform	$134→$128
Jul 9, 2026	RBC Capital	Josh Wolfson	PT Cut	Outperform	$114→$111
Jun 26, 2026	Freedom Broker	Vitaly Kononov	Initiate	Buy	$114
Jun 24, 2026	Roth Capital	Joe Reagor	PT Cut	Buy	$121→$110
Jun 9, 2026	Citigroup	Ephrem Ravi	PT Raise	Buy	$120→$130
Mar 20, 2026	Scotiabank	Tanya Jakusconek	PT Cut	Sector Outperform	$134→$133
Feb 25, 2026	Scotiabank	Tanya Jakusconek	PT Raise	Sector Outperform	$131→$134
Jan 26, 2026	Scotiabank	Tanya Jakusconek	PT Raise	Sector Outperform	$92→$131
Jan 20, 2026	Citigroup	Ephrem Ravi	PT Raise	Buy	$105→$120
Dec 15, 2025	Roth Capital	Joe Reagor	PT Raise	Buy	$84→$92
Dec 10, 2025	Citigroup	Ephrem Ravi	PT Raise	Buy	$90→$105
Dec 3, 2025	JP Morgan	Patrick Jones	PT Raise	Overweight	$128→$131
Nov 12, 2025	Scotiabank	Tanya Jakusconek	PT Raise	Sector Outperform	$90→$92

Analyst Ratings News

This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Neutral on RDW, Overweight on ELOX, Buys on SGHT and AU, and Market Perform on FFIN.

Avi Kapoor

PRO
Goldman Sachs Initiates Coverage On Anglogold Ashanti with Buy Rating, Announces Price Target of $104

Goldman Sachs analyst Matt Greene initiates coverage on Anglogold Ashanti (NYSE:AU) with a Buy rating and announces Price Target of $104.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Anglogold Ashanti, Raises Price Target to $119

RBC Capital analyst Josh Wolfson maintains Anglogold Ashanti (NYSE:AU) with a Outperform and raises the price target from $111 to $119.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Anglogold Ashanti, Raises Price Target to $140

JP Morgan analyst Patrick Jones maintains Anglogold Ashanti (NYSE:AU) with a Overweight and raises the price target from $134 to $140.

Benzinga Newsdesk

This Chewy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Analysts downgraded Chewy, Cooper Companies, AngloGold Ashanti and Crescent Capital BDC, cutting ratings and/or price targets.

Avi Kapoor

PRO
BMO Capital Downgrades Anglogold Ashanti to Market Perform, Maintains Price Target to $115

BMO Capital analyst Raj Ray downgrades Anglogold Ashanti (NYSE:AU) from Outperform to Market Perform and maintains the price target from $115 to $115.

Benzinga Newsdesk

Anglogold Ashanti PLC

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Anglogold Ashanti Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PRO
Goldman Sachs Initiates Coverage On Anglogold Ashanti with Buy Rating, Announces Price Target of $104

PRO
RBC Capital Maintains Outperform on Anglogold Ashanti, Raises Price Target to $119

PRO
JP Morgan Maintains Overweight on Anglogold Ashanti, Raises Price Target to $140

This Chewy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

PRO
BMO Capital Downgrades Anglogold Ashanti to Market Perform, Maintains Price Target to $115

People Also Watch

People Also Watch

Anglogold Ashanti PLC

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Anglogold Ashanti Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PROGoldman Sachs Initiates Coverage On Anglogold Ashanti with Buy Rating, Announces Price Target of $104

PRORBC Capital Maintains Outperform on Anglogold Ashanti, Raises Price Target to $119

PROJP Morgan Maintains Overweight on Anglogold Ashanti, Raises Price Target to $140

This Chewy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

PROBMO Capital Downgrades Anglogold Ashanti to Market Perform, Maintains Price Target to $115

People Also Watch

People Also Watch

PRO
Goldman Sachs Initiates Coverage On Anglogold Ashanti with Buy Rating, Announces Price Target of $104

PRO
RBC Capital Maintains Outperform on Anglogold Ashanti, Raises Price Target to $119

PRO
JP Morgan Maintains Overweight on Anglogold Ashanti, Raises Price Target to $140

PRO
BMO Capital Downgrades Anglogold Ashanti to Market Perform, Maintains Price Target to $115